-
I-BET151 (GSK1210151A) Workflow Guide
2026-09-21
I-BET151 (GSK1210151A), SKU B1500, provides a practical research tool for probing BRD2, BRD3, and BRD4 bromodomain-dependent transcription in cancer biology workflows. It is intended for controlled in vitro and in vivo research, not for diagnostic, therapeutic, or clinical use, and its water insolubility requires deliberate solvent and stock-solution handling.
-
hiPSC-Derived Intestinal Organoids for Pharmacokinetics
2026-09-21
The reference study establishes a streamlined three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. These organoids can be cryopreserved, expanded, and converted into epithelial monolayers containing functional enterocytes, creating a human-relevant platform for cytochrome P450 metabolism and transporter studies.
-
H 89 2HCl: PKA Assay Workflows
2026-09-20
Build cleaner cAMP/PKA experiments with H 89 2HCl by combining concentration control, matched vehicle controls, and orthogonal readouts. The workflow translates neuroinflammation and mechanotransduction findings into practical assays for protein phosphorylation, neurite morphology, and pain-relevant signaling without treating H 89 as a perfectly exclusive kinase probe.
-
NIH/3T3 Cells: Recovery and QC Guide
2026-09-19
NIH/3T3 Cells (BC1017) provide a cryopreserved, adherent mouse fibroblast starting material for controlled culture, transfection, viral proliferation research, and oncogene studies. This guide covers recovery, expansion, assay preparation, and QC while distinguishing product specifications from workflow recommendations and limiting claims not supported by the product dossier.
-
Isochlorogenic acid A Research Workflows
2026-09-18
Build reproducible Isochlorogenic acid A assays around solvent control, Fe(III)-coassembled nanoparticles, and hydrogel delivery. This workflow connects natural product research with anti-infection, inflammation, and wound-repair readouts while separating formulation-specific evidence from direct compound effects.
-
Dopamine, cAMP/PKA, and Osteoclast Differentiation
2026-09-18
Wang et al. identify a D2R/cAMP/PKA/CREB pathway through which dopamine suppresses osteoclast differentiation. The study connects neurotransmitter signaling with bone remodeling and shows that restoring adenylate cyclase or PKA activity can reverse dopamine-associated reductions in CREB signaling and osteoclastogenesis.
-
Clarithromycin: A Strategic CYP3A Research Tool
2026-09-17
Clarithromycin is more than a macrolide antibiotic in the laboratory: it is a practical CYP3A inhibitor for mapping drug-drug interactions, statin metabolism interaction, and exposure changes in pharmacokinetic studies. This article connects enzyme-level perturbation with translational study design, formulation control, and cardiovascular relevance.
-
Human iPSC Intestinal Organoids for Pharmacokinetics
2026-09-17
Saito and colleagues developed a more accessible route for generating intestinal organoids from human induced pluripotent stem cells and showed that the resulting cultures can be expanded, cryopreserved, and differentiated into epithelial cells with pharmacokinetically relevant activities. The study supports hiPSC-derived intestinal organoids as a human-relevant complement to animal models and Caco-2 assays for evaluating intestinal drug metabolism, transport, and absorption.
-
AP20187 for Reliable Cell Assay Control
2026-09-16
Learn how AP20187 (SKU B1274) supports controlled fusion protein dimerization in viability, proliferation, reporter, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical controls, stock preparation, interpretation, and vendor-selection criteria.
-
Microfluidic Peptide/RNA Complexes for Pulmonary Delivery
2026-09-16
Ma and colleagues developed a controllable microfluidic method for preparing peptide–siRNA and peptide–mRNA complexes and evaluated their compatibility with vibrating mesh nebulisation. The study found that aerosol generation, RNA binding, and in vitro transfection were retained after nebulisation, supporting LAH4-L1 and PEG12KL4 as candidates for pulmonary RNA delivery research.
-
EDC.HCl: In Vitro Coupling Workflow
2026-09-15
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in controlled laboratory workflows. It is suitable for in vitro peptide synthesis, bioconjugation, and related coupling studies, but the dossier provides no in vivo or clinical data.
-
Early Pheromones and Neurodegeneration in C. elegans
2026-09-15
Peng et al. show that pheromone perception during the L1 stage can reprogram neuronal signaling and accelerate neurodegeneration in adult C. elegans. Their circuit-level model connects ASK and ASI sensory neurons with AIA interneurons, insulin-like signaling, and reduced neuronal autophagy, offering a mechanistic framework for how early environmental cues influence later proteostasis failure.
-
(S)-(+)-Ibuprofen: From Synthesis to Assay
2026-09-14
Discover how (S)-(+)-Ibuprofen functions as a mechanistically interpretable COX inhibitor, from stereochemical identity and synthesis to concentration-dependent assay design. This guide connects biochemical potency with cellular, translational, and environmental readouts.
-
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-09-14
The reference study shows that compressive mechanical stress induces autophagy through a cytoskeleton-dependent process in human cell lines, with microfilaments acting as the principal structural component and microtubules contributing an auxiliary role. Its combination of cytoskeletal polymerization perturbation, fluorescence imaging, and western blotting provides a useful framework for separating mechanical sensing from downstream autophagy responses.
-
MLN2238 and the Proteotoxic Stress Response
2026-09-13
MLN2238 is more than a potent proteasome β5 subunit inhibitor: it is a controllable probe for studying how proteotoxic stress becomes a signaling decision. This article connects β5-biased 20S proteasome inhibition with ROS–JNK–CREB biology and outlines translational workflows for multiple myeloma, lymphoma, and drug-resistance research.